{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-017522","form_type":"8-K","ticker":"ICCC","cik":"0000811641","company_name":"IMMUCELL CORP /DE/","filed_at":"2024-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.985466+00:00","generated_at":"2026-06-05T13:39:58.918575+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ImmuCell extends $1M line of credit to Sept 2025; banks waive debt service covenant","bullets":["Amended $1M line of credit with Gorham Savings Bank, extending maturity to September 11, 2025.","GSB and FAME waived the minimum debt service coverage ratio of 1.35 for the 12-month period ending June 30, 2024.","Original line of credit was dated March 11, 2020; no other material terms changed.","Allonge executed February 22, 2024; waiver approvals occurred February 21 (GSB) and February 26 (FAME)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-017522","json":"https://secwatch.observer/filing/0001213900-24-017522.json","markdown":"https://secwatch.observer/filing/0001213900-24-017522.md","text":"https://secwatch.observer/filing/0001213900-24-017522.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811641/000121390024017522/0001213900-24-017522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811641/000121390024017522/ea0200796-8k_immucell.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T13:39:58.918575+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19a4fe3cb9bf4ce785a674c48212bdef0347a191","claim":"IMMUCELL CORP /DE/ amended credit facility of $1 million with Gorham Savings Bank maturing through September 11, 2025.","evidence_excerpt":"On February 22, 2024, ImmuCell Corporation (the “Company”) entered into an Allonge to and Amendment of Line of Credit (the “Allonge”) between the Company and Gorham Savings Bank (GSB) pursuant to which the Company’s $1 million line of credit with GSB was extended through September 11, 2025.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390024017522/0001213900-24-017522-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"$1 million"},{"label":"Counterparty","value":"Gorham Savings Bank"},{"label":"Maturity","value":"through September 11, 2025"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"6e473d751385047267b9f1d8f49fe81ded6e060a","claim":"IMMUCELL CORP /DE/ amended Allonge to and Amendment of Line of Credit with Gorham Savings Bank valued at $1 million line of credit extended through September 11, 2025 (effective 2024-02-22).","evidence_excerpt":"On February 22, 2024, ImmuCell Corporation (the “Company”) entered into an Allonge to and Amendment of Line of Credit (the “Allonge”) between the Company and Gorham Savings Bank (GSB) pursuant to which the Company’s $1 million line of credit with GSB was extended through September 11, 2025.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390024017522/0001213900-24-017522-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Gorham Savings Bank"},{"label":"Value","value":"$1 million line of credit extended through September 11, 2025"},{"label":"Effective","value":"2024-02-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}